Skip to content

Treatment for Osgood Schlatter Patients With a Physiotherapy Program

Treatment for Osgood Schlatter Patients With a Physiotherapy Program TrOPhy-Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04716608
Acronym
TrOPhy
Enrollment
36
Registered
2021-01-20
Start date
2020-11-11
Completion date
2022-07-07
Last updated
2022-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osgood-Schlatter Disease

Keywords

myofascial massage, stretching, home exercises, strengthening, KOOS-Child-Questionnaire

Brief summary

This study is to compare the effect of a physiotherapy program to usual care treatment in patients with Osgood Schlatter disease (OSD). Patients will be randomly assigned into two groups. Group 1 will receive the physiotherapy program with myofascial massage, while group 2 (usual care group USC) will receive usual care treatment.

Interventions

physiotherapy program with Myofascial Release Massage, stretching, strengthening. 2 sessions per week (duration 30 minutes per session) for 8 weeks, supervised by a physiotherapist; complemented by a home training program.

stretching,strengthening; 2 sessions per week (duration 30 minutes per session) for 8 weeks

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

randomised controlled parallel groups

Eligibility

Sex/Gender
ALL
Age
10 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Uni- or bilateral OSD * ability to follow instructions * sufficient knowledge of German * availability: can participate in two exercise sessions per week for a period of 8 weeks

Exclusion criteria

* any history of knee surgery * medication intake affecting the knee * unstable fractures * neurological disorders * systematic diseases * already in physiotherapeutic treatment because of the knee * not possible to do any physiotherapy sessions at the Universitäts-Kinderspital Basel (UKBB)

Design outcomes

Primary

MeasureTime frameDescription
change in Knee and Osteoarthritis Outcome Score for Children (KOOS-Child-Questionnaire Score)at baseline and 8 weeks after baselineKOOS-Child is a patient-reported outcome measure employing five-item Likert scales. KOOS-Child covers 5 dimensions (subscales): Pain, Symptoms (titled Knee problems in the KOOS-Child), Difficulty during daily activities (ADL), Function in sport and play (Sports/Play) and knee-related Quality of Life (QOL). 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems

Secondary

MeasureTime frameDescription
Change in Knee pain assessed by Visual Analogue Scale (VAS)at baseline and 8 weeks after baselineThe visual analogue scale (VAS) is a scale used to determine the pain intensity experienced by individuals. It consists of a line, 10 cm in length, with the left side signifying no pain and the right side signifying the worst pain ever.
Change in Range of motion (ROM) of kneeat baseline and 8 weeks after baselineRange of motion is typically measured using a goniometer. Normal ROM at the knee is considered to be 0 degrees of extension (completely straight knee joint) to 135 degrees of flexion (fully bent knee joint).
Change in Y Balance Test (Lower Quarter)at baseline and 8 weeks after baselineThe Y-Balance Test is a dynamic test performed in a single-leg stance that requires strength, flexibility, core control and proprioception. The goal of this test is to maintain single-leg balance on one leg while reaching as far as possible with the contralateral leg in three different directions. The three movement directions are anterior, posteromedial and posterolateral, performed on each leg. Each test is repeated three times, and the maximum reach in each direction is recorded.
Time of return to sport activity (in days)within 8 weeks after baselineTime of return to sport activity (in days) since start of treatment

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026